E-viri
Recenzirano
-
O'Quinn, John W., MD; Santucci, Stephanie, RN; Pham, Diana; Chad, Zave H., MD, FRCPC; MacLusky, Ian, MD; Reisman, Joseph, MD; Yang, William H., MD
Journal of allergy and clinical immunology, 02/2015, Letnik: 135, Številka: 2Journal Article
Conclusions Early treatment of moderate to severe asthma with omalizumab in adolescent/pediatric patients may improve quality of life and help prevent health concerns associated with side effects and/or long term use of ICS and OCS in growing children.
